Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides …
… chronic obstructive pulmonary disease (“COPD“) and assigned a Prescription Drug User Fee Act (“PDUFA”) target action date of June 26, 2024. “The …
… chronic obstructive pulmonary disease (“COPD“) and assigned a Prescription Drug User Fee Act (“PDUFA”) target action date of June 26, 2024. “The …
